Wheezing after respiratory tract infection in athletes

Current Sports Medicine Reports

Volumn 11, Issue 2, 2012, Pages 85-89

  Fields, Karl B ^a   Thekkekandam, Thomas J ^b   Neal, Sara ^a  

^a Moses Cone Sports Medicine Center   (United States)

^b Moses Cone Family Medicine Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; MACROLIDE;

ACUTE SINUSITIS; ARTICLE; ASTHMA; ATHLETE; BRONCHOSPASM; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; EXERCISE INDUCED BRONCHCONSTRICTION; EXERCISE TEST; EXPIRED AIR; HUMAN; LUNG FUNCTION TEST; MEDICAL HISTORY; MEDICAL PRACTICE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PHYSICAL EXAMINATION; POSTNASAL DRIP; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

EID: 84863658132     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e31824a78fc     Document Type: Article

References (45)

1. Al-Bazzaz F, Grillo H, Kazemi H. Response to exercise in upper airway obstruction. Am. Rev. Respir. Dis. 1975; 111:631-40.
2. Amsden GW. Anti-inflammatory effects of macrolides -an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J. Antimicrob. Chemother. 2005; 55:10-21. (Pubitemid 40192609)
3. Anderson S, Seale JP, Ferris L, et al. An evaluation of pharmacotherapy for exercise-induced asthma [review]. J. Allergy Clin. Immunol. 1979; 64(pt 2):612-24. (Pubitemid 10172842)
4. Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin. Infect. Dis. 2004; 38:1341-6. (Pubitemid 38668576)
5. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993; 306:1034-7. (Pubitemid 23105961)
6. Cazzola M, Matera MG, Blasi F. Macrolide and occult infection in asthma. Curr. Opin. Pulm. Med. 2004; 10:7-14. (Pubitemid 38045895)
7. Chirgwin K, Roblin PM, Gelling M, et al. Infection with Chlamydia pneumoniae in Brooklyn. J. Infect. Dis. 1991; 163:757-61.
8. de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 1998; 317:632-7. (Pubitemid 28403489)
9. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 1994; 148:727-32. (Pubitemid 24218479)
10. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003; 163:487-94. (Pubitemid 36244917)
11. Forgacs P. The functional basis of pulmonary sounds. Chest. 1978; 73:399-405. (Pubitemid 8312549)
12. Friman G, Larsson E, Rolf C. Interaction between infection and exercise with special reference to myocarditis and the increased frequency of sudden deaths among young Swedish orienteers 1979-92 [review]. Scand. J. Infect. Dis. Suppl. 1997; 104:41-9.
13. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 1993; 168:1231-5. (Pubitemid 23317140)
14. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann. Allergy Asthma Immunol. 1998; 81:339-44. (Pubitemid 28498999)
15. Heath GW, Ford ES, Craven TE, et al. Exercise and the incidence of upper respiratory tract infections. Med. Sci. Sports Exerc. 1991; 23:152-7.
16. Heir T, Aanestad G, Carlsen KH, Larsen S. Respiratory tract infection and bronchial responsiveness in elite athletes and sedentary control subjects. Scand. J. Med. Sci. Sports. 1995; 5:94-9.
17. Hollingsworth HM. Wheezing and stridor [review]. Clin. Chest Med. 1987; 8:231-40.
18. Ilbäck NG, Fohlman J, Friman G. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction. Am. Heart J. 1989; 117:1298-302. (Pubitemid 19150760)
19. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med. 1998; 338:581-7. (Pubitemid 28114646)
20. King DK, Thompson BT, Johnson DC. Wheezing on maximal forced exhalation in the diagnosis of atypical asthma. Lack of sensitivity and specificity. Ann. Intern. Med. 1989; 110:451-5. (Pubitemid 19088227)
21. Kostka T, Berthouze SE, Lacour J, Bonnefoy M. The symptomatology of upper respiratory tract infections and exercise in elderly people. Med. Sci. Sports Exerc. 2000; 32:46-51. (Pubitemid 30056957)
22. Krafczyk MA, Asplund CA. Exercise-induced bronchoconstriction: diagnosis and management. Am. Fam. Physician. 2011; 84:427-34.
23. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Engl. J. Med. 1998; 339:147-52. (Pubitemid 28328478)
24. Lorenc TM, Kernan MT. Lower respiratory infections and potential complications in athletes [review]. Curr. Sports Med. Rep. 2006; 5:80-6.
25. Matthews CE, Ockene IS, Freedson PS, et al. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med. Sci. Sports Exerc. 2002; 34:1242-8. (Pubitemid 34840021)
26. Meslier N, Charbonneau G, Racineux JL. Wheezes [review]. Eur. Respir. J. 1995; 8:1942-8.
27. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006; 129:39-49. (Pubitemid 43265241)
28. Miettinen OS, Flegel KM, Steurer J. Clinical diagnosis of pneumonia, typical of experts. J. Eval. Clin. Pract. 2008; 14:343-50. (Pubitemid 351347713)
29. Mikami R, Murao M, Cugell DW, et al. International Symposium on Lung Sounds. Synopsis of proceedings. Chest. 1987; 92:342-5. (Pubitemid 17118582)
30. National Asthma Education and Prevention Program: Expert Panel Report III: Guidelines for the Diagnosis and Management of Asthma [Internet]. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007. NIH publication no. 08-4051. Available from: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.
31. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006; 129:15-26. Erratum in: Chest. 2006; 129:1393. (Pubitemid 43265239)
32. Nystad W, Harris J, Borgen JS. Asthma and wheezing among Norwegian elite athletes. Med. Sci. Sports Exerc. 2000; 32:266-70. (Pubitemid 30108102)
33. Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch. Intern.Med. 1989; 149:2277-82. (Pubitemid 19258173)
34. Pratter MR, Hingston DM, Irwin RS. Diagnosis of bronchial asthma by clinical evaluation. An unreliable method. Chest. 1983; 84:42-7. (Pubitemid 13073619)
35. Reiss TF, Hill JB, Harman E, et al. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax. 1997; 52: 1030-5. (Pubitemid 27515780)
36. Sasazuki S, Sasaki S, Tsubono Y, et al. Effect of vitamin C on common cold: randomized controlled trial. Eur. J. Clin. Nutr. 2006; 60:9-17. (Pubitemid 43731069)
37. Shaheen SO, Sterne JA, Tucker JS, Florey CD. Birth weight, childhood lower respiratory tract infection, and adult lung function. Thorax. 1998; 53:549-53. (Pubitemid 28335513)
38. Singh M, Das RR. Zinc for the common cold [review]. Cochrane Database Syst. Rev. 2011; 2:CD001364. DOI: 10.1002/14651858.CD001364.pub3.
39. Stempel DA, Boucher RC. Respiratory infection and airway reactivity [review]. Med. Clin. North Am. 1981; 65:1045-53. (Pubitemid 12208172)
40. Suttithawil W, Ploysongsang Y, Nunthapisud P, Fuangtong R. Acute primary Chlamydophila pneumoniae bronchitis and bronchial hyperresponsiveness in young nonasthmatic Thai military recruits. Ann. Allergy Asthma Immunol. 2007; 99:413-8. (Pubitemid 350086199)
41. Vilsvik J, Ankerst J, Palmqvist M, et al. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Respir. Med. 2001; 95:484-90. Erratum in:Respir. Med. 2001; 95:769. (Pubitemid 32622002)
42. Weidner TG, Anderson BN, Kaminsky LA, et al. Effect of a rhinoviruscaused upper respiratory illness on pulmonary function test and exercise responses. Med. Sci. Sports Exerc. 1997; 29:604-9. (Pubitemid 27193745)
43. Wongtim S, Mogmued S. Methacholine inhalation challenge in patients with post-Mycoplasma pneumoniae pneumonia. Asian Pac. J. Allergy Immunol. 1995; 13:5-10.
44. World Anti-Doping Association. World Anti-Doping Association 2012 Prohibited Drug List. [Internet]. 2012. Available from: http://www.wadaama. org/Documents/World-Anti-Doping-Program/WADP-Prohibited-list/To-be-effective/ WADA-Prohibited-List-2012-EN.pdf.
45. Xepapadaki P, Koutsoumpari I, Papaevagelou V, et al. Atypical bacteria and macrolides in asthma. Allergy Asthma Clin. Immunol. 2008; 4:111-6.